Form 8-K - Current report:
SEC Accession No. 0001193125-25-203554
Filing Date
2025-09-15
Accepted
2025-09-15 16:09:14
Documents
12
Period of Report
2025-09-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K neog-20250912.htm   iXBRL 8-K 48590
2 EX-99.1 neog-ex99_1.htm EX-99.1 9291
3 EX-99.2 neog-ex99_2.htm EX-99.2 10250
  Complete submission text file 0001193125-25-203554.txt   179358

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT neog-20250912.xsd EX-101.SCH 25023
14 EXTRACTED XBRL INSTANCE DOCUMENT neog-20250912_htm.xml XML 4730
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 251314408
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)